Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Vaccine. 2007 Jan 24;25(17):3263–3269. doi: 10.1016/j.vaccine.2007.01.073

Figure 1.

Figure 1

Percent specific lysis by peripheral blood mononuclear cells for infected cells at the times noted after administering inactivated influenza vaccine with (15 subjects) or without QS21 adjuvant (15 subjects). Results are means for the different effector:target cell ratios when A/Taiwan/1/86 (H1N1) or B/Panama/45/90 infected cells were used as both stimulator and target cells.

HHS Vulnerability Disclosure